GlassScriptPhysician profile
Bryan M Grossman
NPI 1801467790
$5,581.24
in general payments reported to CMS, 2019-2025
20 companies · $1,577 in 2025
The $1,577 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $848 · 2023: $1,728 · 2024: $1,428 · 2025: $1,577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,707 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,707.44 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,007.39 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $910.51 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $643.30 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $619.65 | 2022-2025 | Tyrvaya, Ryzumvi |
| Rxsight INC | $513.54 | 2022-2025 | Rxsight Contact Lens, Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Lumenis Be INC | $369.79 | 2023 | Optilight |
| Dompe US, INC. | $333.82 | 2022-2025 | Oxervate |
| Alcon Vision LLC | $266.37 | 2022-2025 | Tryptyr, Clareon, Simbrinza |
| Lkc Technologies, INC. | $228.52 | 2025 | |
| Abbvie INC. | $157.26 | 2023-2024 | |
| Apellis Pharmaceuticals, INC. | $147.37 | 2024-2025 | Syfovre |
| Sun Pharmaceutical Industries INC. | $80.89 | 2023 | Cequa |
| Harrow Eye, LLC | $78.09 | 2024-2025 | Vevye, Tobradex St, Natacyn |
| Amgen INC. | $58.45 | 2025 | Tepezza |
| Sight Sciences, INC. | $44.71 | 2022-2023 | Omni Surgical System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $41.77 | 2024 | Purified Cortrophin Gel |
| Tearlab Corp | $24.48 | 2023 | Tearlab Osmolarity System |
| Johnson & Johnson Surgical Vision, INC. | $21.09 | 2023 | Tecnis Iol |
| Glaukos Corporation | $17.36 | 2024 | Ce-Marked Kxla System |
| Rayner Intraocular Lenses Limited | $16.88 | 2024 | Omidria |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Grossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.